138 related articles for article (PubMed ID: 23268562)
1. High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy.
Leclercq P; Goujard C; Duracinsky M; Allaert F; L'henaff M; Hellet M; Meunier JP; Carret S; Thevenon J; Ngo Van P; Pialoux G
AIDS Res Hum Retroviruses; 2013 May; 29(5):761-8. PubMed ID: 23268562
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
3. People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.
Alencastro PR; Barcellos NT; Wolff FH; Ikeda ML; Schuelter-Trevisol F; Brandão AB; Fuchs SC
BMC Res Notes; 2017 Jan; 10(1):40. PubMed ID: 28086977
[TBL] [Abstract][Full Text] [Related]
4. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
[TBL] [Abstract][Full Text] [Related]
5. Objective assessment of facial lipoatrophy changes in a cohort of HIV-infected patients taking combination antiretroviral therapy.
Yang Y; Yap M; Oo Tha N; Paton NI
HIV Clin Trials; 2008; 9(6):399-406. PubMed ID: 19203905
[TBL] [Abstract][Full Text] [Related]
6. Treatment of facial lipoatrophy with polymethylmethacrylate among patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): impact on the quality of life.
Quintas RC; de França ER; de Petribú KC; Ximenes RA; Quintas LF; Cavalcanti EL; Kitamura MA; Magalhães KA; Paiva KC; Filho DB
Int J Dermatol; 2014 Apr; 53(4):497-502. PubMed ID: 24602032
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
van Griensven J; De Naeyer L; Mushi T; Ubarijoro S; Gashumba D; Gazille C; Zachariah R
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756
[TBL] [Abstract][Full Text] [Related]
8. The impact of facial lipoatrophy treatment with polymethyl methacrylate in AIDS patients as measured by four quality-of-life questionnaires.
Warde M; Gragnani A; Gomes H; Hochman B; Ferreira LM
Int J STD AIDS; 2011 Oct; 22(10):596-9. PubMed ID: 21998182
[TBL] [Abstract][Full Text] [Related]
9. [A study of HIV-related lipodystrophy syndrome in 55 HIV-infected Chinese adult patients].
Zhang L; Li M; Tao MM; Qiu ZF; Xie J; Han Y; Yu W; Li TS
Zhonghua Nei Ke Za Zhi; 2009 Feb; 48(2):118-21. PubMed ID: 19549465
[TBL] [Abstract][Full Text] [Related]
10. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
[TBL] [Abstract][Full Text] [Related]
11. Lipodystrophy syndrome in HIV treatment-multiexperienced patients: implication of resistin.
Arama V; Munteanu DI; Streinu Cercel A; Ion DA; Mihailescu R; Tiliscan C; Tudor AM; Arama SS
J Endocrinol Invest; 2014 Jun; 37(6):533-9. PubMed ID: 24532267
[TBL] [Abstract][Full Text] [Related]
12. Adherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy.
Turcinov D; Stanley C; Rutherford GW; Novotny TE; Begovac J
Eur J Epidemiol; 2009; 24(5):267-74. PubMed ID: 19322667
[TBL] [Abstract][Full Text] [Related]
13. Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.
Piloya T; Bakeera-Kitaka S; Kekitiinwa A; Kamya MR
J Int AIDS Soc; 2012 Jul; 15(2):17427. PubMed ID: 22814353
[TBL] [Abstract][Full Text] [Related]
14. A 39-year-old man with HIV-associated lipodystrophy.
Fuller J
JAMA; 2008 Sep; 300(9):1056-66. PubMed ID: 18677013
[TBL] [Abstract][Full Text] [Related]
15. Discordance between body mass index and anthropometric measurements among HIV-1-infected patients on antiretroviral therapy and with lipoatrophy/lipohypertrophy syndrome.
Soares LR; da Silva DC; Gonsalez CR; Batista FG; Fonseca LA; Duarte AJ; Casseb J
Rev Inst Med Trop Sao Paulo; 2015; 57(2):105-10. PubMed ID: 25923888
[TBL] [Abstract][Full Text] [Related]
16. Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy.
Crane HM; Grunfeld C; Harrington RD; Uldall KK; Ciechanowski PS; Kitahata MM
HIV Med; 2008 Oct; 9(9):780-6. PubMed ID: 18754804
[TBL] [Abstract][Full Text] [Related]
17. Long-term complications of antiretroviral therapy: lipoatrophy.
Waters L; Nelson M
Int J Clin Pract; 2007 Jun; 61(6):999-1014. PubMed ID: 17504362
[TBL] [Abstract][Full Text] [Related]
18. Lipodystrophy and reversal of facial lipoatrophy in perinatally HIV-infected children and adolescents after discontinuation of stavudine.
Sawawiboon N; Wittawatmongkol O; Phongsamart W; Prasitsuebsai W; Lapphra K; Chokephaibulkit K
Int J STD AIDS; 2012 Jul; 23(7):497-501. PubMed ID: 22844004
[TBL] [Abstract][Full Text] [Related]
19. Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imaging.
Paton NI; Yang Y; Tha NO; Sitoh YY
HIV Clin Trials; 2007; 8(4):227-34. PubMed ID: 17720663
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy.
Kinabo GD; Sprengers M; Msuya LJ; Shayo AM; van Asten H; Dolmans WM; van der Ven AJ; Warris A
Pediatr Infect Dis J; 2013 Jan; 32(1):39-44. PubMed ID: 23038217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
